In patients with type 2 diabetes (T2DM), miR-1908-5p can target EXO1, thereby inhibiting the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells, thereby increasing the risk of fractures (20). The gene discussed is EXO1; the disease is type 2 diabetes mellitus.